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Chapter 1
Starting a program for endovascular thoracic
procedures: Challenges and solutions
Mark K. Eskandari, MD, Chicago, IllINTRODUCTION
Endoluminal exclusion of thoracic aortic aneurysms
(TAAs) is now more than theoretically appealing, in large
part because of the availability of an approved device.
Currently, only the Gore Thoracic Aortic Graft (TAG)
endoprosthesis (W. L. Gore & Associates, Inc, Flagstaff,
Ariz) has United States Food and Drug Administration
(FDA) approval for the treatment of TAAs.1 Other devices
will likely follow suit in the near future, including the
Talent Endoluminal Stent-Graft System (Medtronic AVE,
Inc, Santa Rosa, Calif) and the Cook Thoracic Stent-Graft
(Cook Inc, Bloomington, Ind).2-3
The development of a successful endovascular thoracic
aneurysm program requires more than just devices, how-
ever. An institutional commitment, not only in the form of
capital expenditures but also with regard to subspecialty
overlap, is mandatory. Although the treatment of periph-
eral vascular disease has traditionally been managed by
vascular surgeons, the development of minimally invasive
endovascular therapies is also in the hands of interventional
radiologists, interventional cardiologists, and, for thoracic
aneurysms, cardiothoracic surgeons. This chapter reviews
some of the local challenges that must be overcome to
establish a successful endovascular thoracic aortic aneurysm
program.
CAPITAL EXPENSES
Imaging systems. Successful endovascular treatment
in all vascular beds requires optimal imaging, and this is
particularly important in the case of TAA repair. Although
this is a procedure that can be performed with the use of a
portable fluoroscopic imaging unit (ie, OEC 9800, GE
Healthcare, Milwaukee, Wisc) and a corresponding table,
this is not optimal for a number of reasons, including poor
image quality, limited rotational ability, small field of view,
and tendency to “overheating.” The tortuosity of the tho-
racic aorta and proximity to crucial vessels such as the
subclavian, carotid, and celiac arteries mandate the ability
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relation to the aneurysm and intended “seal zones.” Ad-
junctive imaging with intravascular ultrasound or trans-
esophageal echocardiography may be helpful but requires
more equipment and added skills, including performing the
procedure and interpreting the information.4
Inadequate visualization of the anatomy can lead to
devastating complications, ranging from inadvertent cover-
age of arch or visceral vessels to missing a proximal type I
endoleak or dissection. Intraprocedural imaging is more
extensively covered in a separate chapter, but suffice it to say
here that a fixed fluoroscopic unit with a wide field of view
(ie, 15-inch image intensifier) is ideal.
Another aspect of imaging that deserves mention is that
of preprocedural and postprocedural follow-up. Much of
the decision to use an endograft for a thoracic aneurysm is
dependent on the objective measurements obtained on
thin-cut, high-resolution computed tomography (CT)
scans and diagnostic angiography. The latter is less fre-
quently used with improvements in CT imaging and three-
dimensional-rendered images. CT is needed to choose the
appropriate size and length of devices and to identify seal
zones, anomalous anatomy, extent of calcification, vessel
tortuosity, and intraluminal thrombus load. After implan-
tation, CT is used to document complete exclusion of the
aneurysm and to detect endoleaks, vessel coverage, retro-
grade dissection, migration, or component failure (ie, frac-
ture, kinking, and fabric tears).5 Needless to say, availability
of high-quality CT imaging is a must.
Procedurals suite. The prerequisite of high-resolution
image guidance is a natural introduction to where these
procedures should best be done. Thoracic endografts have
been designed to be delivered transfemorally, either through
an open approach or percutaneously; however, anatomic
constraints may necessitate alternative entry sites.6 Most
frequently this is through a retroperitoneal approach to the
iliac vessels or infrarenal aorta. In the operating room this is
readily achieved, whereas in an interventional suite it can be
fraught with the problems of poor lighting, insufficient
technical assistance, and an inadequate sterile environment.
Additionally, performing these procedures in a fully func-
tional operating room allows the operator to deal with
unexpected complications in an expeditious manner with
complete anesthetic support.
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tems come with some of the basic tools for deployment,
including sheaths and balloons; however, a cadre of other
items is required. The bare essentials are a stiff 0.035-inch 
300-cm exchange length wire and a diagnostic catheter.
Unfortunately, most thoracic aneurysm stent-graft cases
use much more equipment than initially anticipated. It is
therefore important to have a variety of other interventional
devices readily at hand. This requires a stockpile of items,
including stiff and floppy wires, hydrophilic wires, selective
catheters, and additional balloons and stents. The latter
may be called upon to manage access vessel interventions
for a pre-existing stenosis or iatrogenic injury and should
include balloon-expandable stents, self-expanding stents,
and covered stents.
Although the goal is to proceed with only a femoral
puncture or cutdown, adjunctive surgical procedures are
sometimes indicated that require additional surgical equip-
ment. This may come in the form of a planned concomitant
procedure, anticipated additional procedure, or emergent
operation. Potential concomitant or additional procedures
include carotid-subclavian transposition/bypass or a retro-
peritoneal incision to access more proximal arteries capable
of accommodating the stent-graft delivery system. Al-
though infrequent, emergent operations are sometimes
needed to manage access vessel trauma (ie, rupture, dissec-
tion, thrombosis, or embolization), device failure, or inad-
vertent coverage of a critical vessel.7-9 The tools for these
operations should be in the room and available.
STAFFING
Anesthetic care. Many endoluminal interventions can
be done with either local anesthesia or minimal sedation
and thus require little in the way of adjunctive support from
anesthetists, nurses, or radiologic technicians. Endovascu-
lar treatment of TAAs may eventually evolve into a similar
state, but for the time being, this is not feasible. A team
approach is essential. It is recommended that these cases be
performed under general anesthesia to facilitate easier
blood pressure control, minimize patient movement, and
allow for an unencumbered transition to a conduit if nec-
essary. Anesthetic support may be needed if spinal drainage
is to be incorporated as part of the treatment algo-
rithm.10-11 This includes placement of the drainage cathe-
ter as well as monitoring the transduced pressure and total
volume removed during the case. In many centers, the
anesthesia team also has the equipment and is responsible
for obtaining and measuring the activated clotting time
(ACT) after the administration of systemic heparin.
Technical support. Any scrub assistants at the table
should be facile at endovascular interventions as well as
open surgical techniques. This includes prior working
knowledge in preparing wires, catheters, sheaths, and the
devices themselves. It is critical to remove all the air from
these devices before introduction to minimize the risk of air
embolization to end organs. An inexperienced assistant
jeopardizes a successful procedure and should not be toler-ated. Training can be gained either on site through formal
in-service programs or off site at centers of excellence.
The last member of the team is the radiologic techni-
cian. This individual’s responsibility is highly dependent on
the imaging equipment available. The more sophisticated
the equipment (ie, fixed unit with tableside controls), the
less involved he or she will be. Managing the power injector
may be an additional responsibility for the technician, un-
less an injector with a sterile, handheld control is available
to prepare and operate the device.
SUBSPECIALTY OVERLAP
Thoracic stent-graft repair is analogous to many other
therapies in medicine in that it is not exclusive to one
particular specialty. The procedure has a number of techni-
cal components that dictate its inclusion in vascular surgery,
cardiothoracic surgery, interventional radiology, and inter-
ventional cardiology. Although the former two may have a
better understanding of the pathology, natural history, and
indications for treatment, the latter two may be more
skilled at the endoluminal techniques required to treat the
patient. Much of this has changed in recent years with the
introduction of stent-grafts for infrarenal aortic aneurysms
and, as a result, quite a bit of subspecialty overlap exists,
such that these groups often function independently. Al-
though this is reasonable, my personal bias is to work
together in a collaborative effort, so that each group’s
particular skill may provide added benefit to the patient.
Finances aside, this certainly requires a collegial approach
and the avoidance of turf wars. Guidelines in clinical com-
petencies and privileging, covered in a separate chapter,
may help collaborative efforts; however, these are typically
locally controlled.
REFERRAL BASE
The final component of developing a successful endo-
vascular TAA repair program is to establish a strong referral
base. Success in this arena is dependent on demonstrating
success with the new therapy and providing timely feedback
to referring physicians. Careful patient selection is obvi-
ously important in achieving good results in the early phase
of development. Such a program should also be able to
provide standard open surgical options with comparable out-
comes. Providing continuing medical education-sponsored
events open to internists, cardiologists, radiologists, and
vascular and cardiothoracic surgeons is an alternative means
of presenting outcomes using both treatment paradigms.
By providing traditional care options as well as cutting-
edge technologic advancements, a dedicated group of phy-
sicians can grow into a respected, regional referral center.
CONCLUSION
Clinical trials support the early success of endoluminal
exclusion of TAAs and have led to the availability of an
approved device. Centers with a strong will to develop a
well-rounded program to treat these difficult aneurysms
can achieve success with a dedicated approach. Develop-
ment of an endovascular TAA repair program requires
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lar equipment, well-trained personnel, and a collegial envi-
ronment. Although this can be an expensive and laborious
endeavor, the end result is rewarded by improved patient
recovery and outcomes.
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